EU legislation gives directives, how pharmaceuticals shall be manufactured and treated throughout the value chain. These requirements are written in guidelines on Good Distribution Practice (GDP), which is a minimum standard for all distribution companies. All companies are audited externally by local authorities and principal medical companies on regular basis. On top of that each of Oribalt busineses has its own self-control procedures to make sure, that all requirements will be met.
In Quality Assurance Oribalt is developing its cold chain handling systems and implementing the state of the art solutions first in the market e.g. on-line monitoring of temperature controlled deliveries, own designed and dedicated temperature controlled totes and other features.